NEU 0.00% $17.09 neuren pharmaceuticals limited

Below benchmark for 1st month, page-34

  1. 388 Posts.
    lightbulb Created with Sketch. 243
    Neuren have done a totally awesome job on this development except for continually failing to meet the publicly stated timing expectations. I think the SP is more a reflection of everyone having the same frustration as you Stew.

    I think the product is a go, but there is no confidence in timing. I have waited this long so going to ride it out, but the frustration is not knowing if we are going to hit the new pushed out dates or they are going to find a reason to delay further.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.